CPE-20893-16357
3 vaccinations
6 coded responses
28 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 342 / FL
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-22
Registered in v-safe
-
2021-03-22
Dose 1 — Moderna
- 2021-03-22
-
2021-03-23
Survey response — days 1–6 daily, dose 1MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Site: Pain, Redness, SwellingFree text: Systemic sarcodosis slightly flare upMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-24
- 2021-03-25
- 2021-03-27
- 2021-03-28
- 2021-03-29
-
2021-04-07
Survey response — day 14, dose 1MedDRA: Anosmia, Dizziness, Sinus headache — Feeling: Good · Be unable to do your normal daily activitiesFree text: Last 2 days pSinus headache, loss of smell, dizziness when bending and rising lasting about 45 seconds. Considering a doctor visit.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-12
-
2021-04-19
Dose 2 — Moderna
- 2021-04-19
-
2021-04-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-04-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · HeadacheAdult check-in
- 2021-04-22
- 2021-04-24
- 2021-04-26
- 2021-05-03
- 2021-05-17
- 2021-05-24
- 2021-06-02
- 2021-07-19
-
2021-10-18
Survey response — 6 months, dose 2MedDRA: Cerebral small vessel ischaemic disease — Feeling: Good · Be unable to do your normal daily activitiesFree text: Diagnosed with small vessel disease.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-22
Survey response — 12 months, dose 2MedDRA: Condition aggravated, Muscular weakness, Nervous system disorder, Pre-existing disease, Respiratory tract irritation — Feeling: Good · Be unable to do your normal daily activitiesFree text: Systemic sarcodoisis flare up. Increased muscle weakness and neurological symptoms and left lung irritation.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-03
Dose 3 — Moderna
-
2022-05-14
Health check-in — day 7, dose 3Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2022-05-17
Survey response — day 14, dose 3MedDRA: Headache, Malaise, Pain — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Progressive malaise symotoms and shooting pain, headache. No feverMedDRA releases: 2024-11 · check-in free text available
-
2022-05-31
Survey response — day 28, dose 3MedDRA: Muscular weakness — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Increased muscle weaknessMedDRA releases: 2024-11 · check-in free text available
- 2022-06-07
- 2022-08-02
- 2022-11-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Moderna | |
| 2 | 2021-04-19 | Moderna | |
| 3 | 2022-05-03 | Moderna | No |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Systemic sarcodosis slightly flare up
Release 7 — day 14, dose 1
Symptoms: Last 2 days pSinus headache, loss of smell, dizziness when bending and rising lasting about 45 seconds. Considering a doctor visit.
Release 10 — 6 months, dose 2
Symptoms: Diagnosed with small vessel disease.
Release 11 — 12 months, dose 2
Symptoms: Systemic sarcodoisis flare up. Increased muscle weakness and neurological symptoms and left lung irritation.
Release 11 — day 14, dose 3
Symptoms: Progressive malaise symotoms and shooting pain, headache. No fever
Release 11 — day 28, dose 3
Symptoms: Increased muscle weakness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | ✓ | ✓ | ✓ |
| SD | Cerebral small vessel ischaemic disease | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Muscular weakness | · | · | ✓ |
| SD | Nervous system disorder | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Respiratory tract irritation | · | · | ✓ |
| SD | Sinus headache | ✓ | ✓ | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release